PATL1

PATL1 (Pat1b) is a multifunctional scaffold protein that coordinates cytoplasmic mRNA decay and processing body (P body) assembly while also participating in nuclear RNA metabolism. In the cytoplasm, PATL1 physically bridges the Ccr4-Caf1-Not deadenylation complex and the Dcp1-Dcp2 decapping complex via distinct domains, directly activating mRNA deadenylation and decapping when tethered to mRNA, and nucleates P body formation through an N-terminal aggregation domain in a stepwise pathway downstream of Rck-mediated translational repression (PMID:20584987, PMID:23535175). PATL1 is a CRM1-dependent nucleocytoplasmic shuttling protein that, in the nucleus, associates with the Lsm2-8/U6 snRNA/SART3 complex in Cajal bodies and regulates alternative splicing of exons with weak splice donors; its depletion also preferentially stabilizes AU-rich element-containing mRNAs (PMID:28768202, PMID:22090346). PATL1 additionally interacts with TFIIE and facilitates transcription of specific mRNAs including hERG (KCNH2), linking it to cardiac electrophysiology (PMID:36608291).

1. 2007 Medium

   Establishing that PATL1 is a P body component whose presence is required for P body integrity answered the fundamental question of where PATL1 functions and identified it as a structural organizer of cytoplasmic mRNA granules.

   Evidence Fluorescence microscopy co-localization with Lsm1/Rck/Dcp1 and RNAi knockdown in human cells

   PMID:17936923

   Open questions at the time

   • Single-lab observation at the time
   • Mechanism by which PATL1 loss dissolves P bodies unknown
   • Whether PATL1 is sufficient or only necessary for P body formation not tested
2. 2010 High

   Demonstrating that PATL1 physically bridges deadenylation and decapping complexes through distinct domains, and that tethered PATL1 activates mRNA deadenylation and repression, established its molecular function as a scaffold coupling sequential steps of mRNA decay.

   Evidence Co-immunoprecipitation with Ccr4-Caf1-Not, Dcp1-Dcp2, Rck, and Lsm1; domain mapping; tethering reporter assays in HeLa cells; IP-MS identification

   PMID:20584987 PMID:20852261

   Open questions at the time

   • Direct RNA-binding specificity of PATL1 not characterized
   • Whether PATL1 enhances decapping catalytic rate or substrate access unclear
   • Structural basis of multi-complex scaffold architecture unknown
3. 2010 High

   Identifying an N-terminal aggregation-prone domain as the P body nucleation element and a separate acidic domain controlling P body size resolved how PATL1 organizes these condensates at a domain-level.

   Evidence Overexpression and domain deletion/mutation analysis with fluorescence microscopy

   PMID:20584987

   Open questions at the time

   • Whether aggregation domain drives liquid-liquid phase separation or amyloid-like assembly not determined
   • Regulation of the aggregation domain (post-translational modifications, binding partners) unknown
4. 2011 High

   Revealing that PATL1 shuttles between cytoplasm and nucleus via a CRM1-dependent NES and localizes to splicing speckles, PML bodies, and nucleolar caps uncovered a dual-compartment function beyond mRNA decay.

   Evidence Leptomycin B treatment, immunofluorescence, domain mapping, and spliceostatin A treatment in human cells

   PMID:22090346

   Open questions at the time

   • Nuclear function at the molecular level not yet defined
   • Signals controlling nuclear import unknown
   • Functional significance of PML body and nucleolar cap association not tested
5. 2012 Medium

   Identifying ALG-2 (PDCD6) as a calcium-dependent interactor of PATL1 in P bodies raised the possibility of calcium-regulated mRNA decay, linking signaling to P body biology.

   Evidence Far-Western blotting, co-immunoprecipitation of endogenous proteins, and immunofluorescence co-localization

   PMID:22437941

   Open questions at the time

   • Single-lab Co-IP plus far-Western; no reciprocal validation or functional consequence shown
   • Whether calcium signaling modulates PATL1 activity or P body dynamics not tested
   • Stoichiometry and in vivo relevance unknown
6. 2013 High

   Using interaction-deficient point mutants to show that Rck requires PATL1 binding for P body assembly while PATL1 acts independently of Rck established a stepwise model: Rck represses translation first, then PATL1 nucleates P bodies and promotes decapping.

   Evidence Point mutagenesis, knockdown/rescue, co-immunoprecipitation, and tethering assays in HeLa cells

   PMID:23535175

   Open questions at the time

   • How translational repression by Rck is communicated to PATL1 recruitment is unclear
   • Whether other factors can substitute for Rck in the first step not tested
7. 2017 High

   Demonstrating that PATL1 forms a nuclear complex with Lsm2-8, U6 snRNA, and SART3 in Cajal bodies and that its depletion alters >180 alternative splicing events defined PATL1's nuclear function in pre-mRNA splicing, complementing its cytoplasmic decay role.

   Evidence Reciprocal Co-IP, immunofluorescence, RNAi followed by RNA-seq in human cells

   PMID:28768202

   Open questions at the time

   • Whether PATL1 directly modulates U4/U6 snRNP recycling or acts indirectly through Lsm2-8 unknown
   • How PATL1 selects regulated exons with weak donor sites not resolved
   • Relative contributions of cytoplasmic mRNA stabilization vs. nuclear splicing changes to the transcriptomic effects of PATL1 depletion unclear
8. 2023 Medium

   Finding that PATL1 interacts with TFIIE and facilitates hERG mRNA transcription extended PATL1's function to transcriptional regulation, with physiological consequences for cardiac action potential duration.

   Evidence Co-immunoprecipitation (PATL1–TFIIE), dual-luciferase reporter assay, siRNA knockdown, and electrophysiology in SH-SY5Y cells and hiPSC-derived cardiomyocytes

   PMID:36608291

   Open questions at the time

   • PATL1 and PATL2 contributions not individually resolved
   • Whether PATL1 acts as a general transcriptional cofactor or is specific to hERG/KCNH2 unknown
   • Single-lab finding not yet independently replicated

• The structural basis for PATL1's multi-domain scaffold function, the regulatory inputs controlling its nuclear-cytoplasmic partitioning, and whether its transcriptional role extends beyond hERG remain unresolved.
• No high-resolution structure of PATL1 or its complexes
• Post-translational modifications regulating PATL1 activity or localization not characterized
• Genome-wide identification of PATL1 direct mRNA targets not performed